Letters

Benign prostatic hyperplasia: Caveat for finasteride should be discussed before prescribing

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7569.654 (Published 21 September 2006) Cite this as: BMJ 2006;333:654
  1. Hussam Ammar, attending physician ([email protected]),
  2. Ashok K Malani, attending physician, internal medicine,
  3. Chakshu Gupta, physician, laboratory medicine and pathology
  1. Heartland Regional Medical Center, 5325 Faraon Street, St Joseph, MO 64506, USA

    EDITOR—Patel and Chapple recommend finasteride as one drug in combination therapy of benign prostatic hyperplasia.1 Finasteride was evaluated for chemoprevention of prostate cancer in a seven year, placebo …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe